KRAS and neoplasm: We also carried out stratified analyses by (a) sex (Supplementary Table S9), (b) tumor stage (Table 1), (c) tumor grade (Table S10), (d) MSI status (Table 2), and by (e) KRAS mutation status (Table S11).